Menon, Tejas http://orcid.org/0000-0001-7636-0051
Illing, Patricia T. http://orcid.org/0000-0002-3870-0796
Chaurasia, Priyanka
McQuilten, Hayley A. http://orcid.org/0000-0002-7089-5300
Shepherd, Chloe
Rowntree, Louise C. http://orcid.org/0000-0002-0649-5089
Petersen, Jan
Littler, Dene R. http://orcid.org/0000-0001-5904-1905
Khuu, Grace
Huang, Ziyi
Allen, Lilith F.
Rockman, Steve
Crowe, Jane
Flanagan, Katie L. http://orcid.org/0000-0002-1575-1953
Wakim, Linda M.
Nguyen, Thi H. O. http://orcid.org/0000-0002-9294-7693
Mifsud, Nicole A. http://orcid.org/0000-0001-8647-2102
Rossjohn, Jamie http://orcid.org/0000-0002-2020-7522
Purcell, Anthony W. http://orcid.org/0000-0003-0532-8331
van de Sandt, Carolien E. http://orcid.org/0000-0002-4155-7433
Kedzierska, Katherine http://orcid.org/0000-0001-6141-335X
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council
Article History
Received: 5 September 2023
Accepted: 3 April 2024
First Online: 29 April 2024
Competing interests
: S.R. is an employee of CSL, a company that produces influenza vaccines. A.W.P. is a scientific advisor for Bioinformatics Solutions Inc (Canada) and Grey Wolf Therapeutics (UK), a shareholder and scientific advisor for Evaxion Biotech (Denmark), and a co-founder of Resseptor Therapeutics (Australia). These interests had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. The remaining authors declare no competing interests.